BRIDGE PHARMA

DEAD

Serial Number

97759618

Owner

Bridgewest International Holdings LLC

Attorney

Lisel M. Ferguson

Filing Date

Jan 18, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

BRIDGE PHARMA Trademark

Serial Number: 97759618

BRIDGE PHARMA is a trademark filed by Bridgewest International Holdings LLC on January 18, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Bridgewest International Holdings LLC (10 trademarks)

701 Brickell Avenue, Suite 1490
Miami, FL 33131

Entity Type: 16

Legal Representation

Attorney of Record

Lisel M. Ferguson

1,234 trademarks filed View all →

Correspondence Address

Lisel M. Ferguson RIMON PC

1655 Fairview Ave., Ste 102

Boise, ID 83702

United States

Trademark Details

Filing Date

January 18, 2023

Registration Date

Not Registered

Goods & Services

Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 25, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 25, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 25, 2025 REAP

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Sep 10, 2024 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Sep 10, 2024 ABN2

REVIEW OF CORRESPONDENCE COMPLETE

Aug 7, 2024 CORV

ATTORNEY REVIEW COMPLETED

Aug 7, 2024 ATRV

DIVISIONAL PROCESSING COMPLETE

Aug 7, 2024 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 6, 2024 AITU

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jun 7, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jun 7, 2024 XELR

DIVISIONAL REQUEST RECEIVED

May 14, 2024 DRRR

TEAS REQUEST TO DIVIDE RECEIVED

May 14, 2024 ERTD

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 7, 2024 GNFN

FINAL REFUSAL E-MAILED

Mar 7, 2024 GNFR

FINAL REFUSAL WRITTEN

Mar 7, 2024 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 25, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 24, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 24, 2024 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 25, 2023 GNRN

NON-FINAL ACTION E-MAILED

Oct 25, 2023 GNRT

NON-FINAL ACTION WRITTEN

Oct 25, 2023 CNRT

ASSIGNED TO EXAMINER

Oct 16, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 25, 2023 NWOS

NEW APPLICATION ENTERED

Jan 21, 2023 NWAP

Related Trademarks

More from this Owner

ORA VILLAS COLLECTION

ORA

ORA VILLAS COLLECTION

ORA

ORA

BRIDGE PHARMA

More in Same Class

DIFF CONSULTING

DIFF CONSULTING

ONTINUE

Serial #97758466

NPM TECHNOLOGIES

NPM TECHNOLOGIES

BUILDINGEASE

N ENGRAM